|
|
Sorafenib-induced pancreatitis
|
|
|
|
|
نویسنده
|
Ayyildiz Talat ,Aydin Taner ,Eminler Ahmet Tarik ,Yildirim Cinar ,Irak Kader ,Kiyici Murat ,Gurel Selim ,Nak Selim Giray ,Gulten Macit ,Dolar Enver
|
منبع
|
journal of experimental and clinical medicine - 2015 - دوره : 32 - شماره : 3 - صفحه:133 -135
|
چکیده
|
Sorafenib is an inhibitor of multikinase proteins which is used for metastaticrenal cell carcinoma and advanced stage hepatocellular carcinoma. its side effects include serum amylase and lipase elevations anticipated to occur within first weeks of treatment but clinically and radiologically evident acute pancreatitis develops rarely. five cases of acute pancreatitis have been reported in literature until date. the case we described here is the sixth case of clinically diagnosed acute pancreatitis.
|
کلیدواژه
|
Hepatocellular carcinoma ,Pancreatitis ,Sorafenib ,Tyrosine kinase inhibitor
|
آدرس
|
Ondokuz Mayis University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Internal Medicine, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey, Uludag University, Faculty of Medicine, Department of Gastroenterology, Turkey
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|